Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.

PloS one - 1 Jan 2015

Snoeck-Stroband Jiska B, Lapperre Therese S, Sterk Peter J, Hiemstra Pieter S, Thiadens Henk A, Boezen H Marike, Ten Hacken Nick H T, Kerstjens Huib A M, Postma Dirkje S, Timens Wim, Sont Jacob K

Abstract excerpt

BACKGROUND: The decline in lung function can be reduced by long-term inhaled corticosteroid (ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD). We aimed to identify which clinical, physiological and non-invasive inflammatory characteristics predict the benefits of ICS on lung function decline in COPD. METHODS: Analysis was performed in 50 steroid-naive compliant patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bronchodilator Agents

Share to Drug Administration Schedule

Share to Forced Expiratory Volume

Share to Pulmonary Disease, Chronic Obstructive

Share to Spirometry

Share to Sputum

Source

Open in PubMed Open full text

Identifiers

PMID: 26659582
DOI: 10.1371/journal.pone.0143793
PMCID: PMC4699453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.PMID 26659582Read ↗

FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD.Semantic proximity Read ↗

Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.Semantic proximity Read ↗

Phenotyping Before Starting Treatment in COPD?Semantic proximity Read ↗

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.Semantic proximity Read ↗

Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss.Semantic proximity Read ↗

Defining phenotypes in COPD: an aid to personalized healthcare.Semantic proximity Read ↗

Phenotypic predictors of response to oral glucocorticosteroids in severe asthma.Semantic proximity Read ↗

Chronic obstructive pulmonary disease: getting it right. Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival?Semantic proximity Read ↗

Phenotype of Spirometric Impairment in an Aging Population.Semantic proximity Read ↗

Multidrug resistance-associated protein 1 and lung function decline with or without long-term corticosteroids treatment in COPD.Semantic proximity Read ↗

COPD phenotypes: differences in survival.Semantic proximity Read ↗

Machine Learning Prediction of Progression in FEV<sub>1</sub>in the COPDGene StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.